{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:07:50Z","timestamp":1792782470893,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Deanship of Research at the Jordan University of Science and Technology","award":["Grant No. 20220524"],"award-info":[{"award-number":["Grant No. 20220524"]}],"id":[{"id":"https:\/\/ror.org\/03y8mtb59","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Chem Res"],"DOI":"10.1007\/s00044-026-03626-2","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T06:49:27Z","timestamp":1790578167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimization of a bis-imine scaffold as a glyoxalase I inhibitor: synthesis, SAR, and docking studies"],"prefix":"10.1007","author":[{"given":"Buthina A.","family":"Al-Oudat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah B.","family":"Al-Omari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suaad A.","family":"Audat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizar A.","family":"Al-Shar\u2019i","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qosay A.","family":"Al-Balas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"issue":"1","key":"3626_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"Cancer J Clin"},{"key":"3626_CR2","doi-asserted-by":"crossref","unstructured":"Mannervik B, Glyoxalase I. Enzymatic basis of detoxification. Academic: New York, NY, USA; 1980.","DOI":"10.1016\/B978-0-12-380002-2.50020-8"},{"issue":"2","key":"3626_CR3","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0021-9258(18)56017-8","volume":"190","author":"E Racker","year":"1951","unstructured":"Racker E. The mechanism of action of glyoxalase. J Biol Chem. 1951;190(2):685\u201396.","journal-title":"J Biol Chem"},{"key":"3626_CR4","first-page":"763","volume":"14","author":"SJ Carrington","year":"1986","unstructured":"Carrington SJ. The glyoxalase enigma. The biological consequences of a ubiquitous enzyme. IRCS Med Sci. 1986;14:763\u20138.","journal-title":"IRCS Med Sci"},{"issue":"4","key":"3626_CR5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1139\/m89-065","volume":"35","author":"K Murata","year":"1989","unstructured":"Murata K, Inoue Y, Rhee H-i, Kimura A. 2-Oxoaldehyde metabolism in microorganisms. Can J Microbiol. 1989;35(4):423\u201331.","journal-title":"Can J Microbiol"},{"issue":"1","key":"3626_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj2690001","volume":"269","author":"PJ Thornalley","year":"1990","unstructured":"Thornalley PJ. The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life. Biochem J. 1990;269(1):1.","journal-title":"Biochem J"},{"key":"3626_CR7","doi-asserted-by":"publisher","first-page":"110663","DOI":"10.1016\/j.biopha.2020.110663","volume":"131","author":"Y He","year":"2020","unstructured":"He Y, Zhou C, Huang M, Tang C, Liu X, Yue Y, et al. Glyoxalase system: A systematic review of its biological activity, related-diseases, screening methods and small molecule regulators. Biomed Pharmacother. 2020;131:110663.","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"3626_CR8","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1042\/CS20140683","volume":"128","author":"DE Maessen","year":"2015","unstructured":"Maessen DE, Stehouwer CD, Schalkwijk CG. The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases. Clin Sci. 2015;128(12):839\u201361.","journal-title":"Clin Sci"},{"issue":"2","key":"3626_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3390\/life14020263","volume":"14","author":"M Alhujaily","year":"2024","unstructured":"Alhujaily M. Molecular assessment of methylglyoxal-induced toxicity and therapeutic approaches in various diseases: exploring the interplay with the glyoxalase system. Life. 2024;14(2):263.","journal-title":"Life"},{"key":"3626_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-018-1801-y","volume":"21","author":"S Trellu","year":"2019","unstructured":"Trellu S, Courties A, Jaisson S, Gorisse L, Gillery P, Kerdine-R\u00f6mer S, et al. Impairment of glyoxalase-1, an advanced glycation end-product detoxifying enzyme, induced by inflammation in age-related osteoarthritis. Arthritis Res Therapy. 2019;21:1\u201312.","journal-title":"Arthritis Res Therapy"},{"issue":"8","key":"3626_CR11","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.3390\/cells10081852","volume":"10","author":"G Aragon\u00e8s","year":"2021","unstructured":"Aragon\u00e8s G, Rowan S, Francisco SG, Whitcomb EA, Yang W, Perini-Villanueva G, et al. The glyoxalase system in age-related diseases: nutritional intervention as anti-ageing strategy. Cells. 2021;10(8):1852.","journal-title":"Cells"},{"issue":"3","key":"3626_CR12","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/jcb.21687","volume":"104","author":"YX Yang","year":"2008","unstructured":"Yang YX, Chen ZC, Zhang GY, Yi H, Xiao ZQ. A subcelluar proteomic investigation into vincristine-resistant gastric cancer cell line. J Cell Biochem. 2008;104(3):1010\u201321.","journal-title":"J Cell Biochem"},{"key":"3626_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1023\/A:1010632919129","volume":"66","author":"A Rulli","year":"2001","unstructured":"Rulli A, Carli L, Romani R, Baroni T, Giovannini E, Rosi G, et al. Expression of glyoxalase I and II in normal and breast cancer tissues. Breast Cancer Res Treat. 2001;66:67\u201372.","journal-title":"Breast Cancer Res Treat"},{"issue":"14","key":"3626_CR14","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1016\/S0959-8049(02)00236-8","volume":"38","author":"E Mearini","year":"2002","unstructured":"Mearini E, Romani R, Mearini L, Antognelli C, Zucchi A, Baroni T, et al. Differing expression of enzymes of the glyoxalase system in superficial and invasive bladder carcinomas. Eur J Cancer. 2002;38(14):1946\u201350.","journal-title":"Eur J Cancer"},{"key":"3626_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s00432-005-0044-x","volume":"132","author":"H-Y Song","year":"2006","unstructured":"Song H-Y, Liu Y-K, Feng J-T, Cui J-F, Dai Z, Zhang L-J, et al. Proteomic analysis on metastasis-associated proteins of human hepatocellular carcinoma tissues. J Cancer Res Clin Oncol. 2006;132:92\u20138.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"3626_CR16","doi-asserted-by":"publisher","first-page":"e34352","DOI":"10.1371\/journal.pone.0034352","volume":"7","author":"W-L Cheng","year":"2012","unstructured":"Cheng W-L, Tsai M-M, Tsai C-Y, Huang Y-H, Chen C-Y, Chi H-C, et al. Glyoxalase-I is a novel prognosis factor associated with gastric cancer progression. PLoS ONE. 2012;7(3):e34352.","journal-title":"PLoS ONE"},{"issue":"20","key":"3626_CR17","doi-asserted-by":"publisher","first-page":"6887","DOI":"10.1158\/1078-0432.CCR-04-0307","volume":"10","author":"J-W Cui","year":"2004","unstructured":"Cui J-W, Wang J, He K, Jin B-F, Wang H-X, Li W, et al. Proteomic analysis of human acute leukemia cells: insight into their classification. Clin Cancer Res. 2004;10(20):6887\u201396.","journal-title":"Clin Cancer Res"},{"key":"3626_CR18","doi-asserted-by":"publisher","first-page":"857746","DOI":"10.3389\/fonc.2022.857746","volume":"12","author":"J Wang","year":"2022","unstructured":"Wang J, Yang X, Wang Z, Wang J. Role of the glyoxalase system in breast Cancer and Gynecological Cancer-Implications for therapeutic intervention: a review. Front Oncol. 2022;12:857746.","journal-title":"Front Oncol"},{"issue":"10","key":"3626_CR19","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3390\/antiox9100939","volume":"9","author":"J Morgenstern","year":"2020","unstructured":"Morgenstern J, Campos Campos M, Nawroth P, Fleming T. The Glyoxalase System\u2014New Insights into an Ancient Metabolism. Antioxidants. 2020;9(10):939.","journal-title":"Antioxidants"},{"issue":"4","key":"3626_CR20","doi-asserted-by":"publisher","first-page":"115243","DOI":"10.1016\/j.bmc.2019.115243","volume":"28","author":"T Jin","year":"2020","unstructured":"Jin T, Zhao L, Wang H-P, Huang M-L, Yue Y, Lu C, et al. Recent advances in the discovery and development of glyoxalase I inhibitors. Bioorg Med Chem. 2020;28(4):115243.","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"3626_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2174\/1389557518666181009141231","volume":"19","author":"QA Al-Balas","year":"2019","unstructured":"Al-Balas QA, Hassan MA, Al-Shar\u2019i NA, Al Jabal GA, Almaaytah AM. Recent advances in glyoxalase-I inhibition. Mini Rev Med Chem. 2019;19(4):281\u201391.","journal-title":"Mini Rev Med Chem"},{"issue":"5","key":"3626_CR22","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.3390\/ijms23052453","volume":"23","author":"N Rabbani","year":"2022","unstructured":"Rabbani N, Thornalley PJ. Emerging glycation-based therapeutics\u2014glyoxalase 1 inducers and glyoxalase 1 inhibitors. Int J Mol Sci. 2022;23(5):2453.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3626_CR23","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/jat.4768","volume":"45","author":"B Guo","year":"2025","unstructured":"Guo B, He X. The Mechanism of Bisphenol S-Induced Atherosclerosis Elucidated Based on Network Toxicology, Molecular Docking, and Machine Learning. J Appl Toxicol. 2025;45(6):1043\u201355.","journal-title":"J Appl Toxicol"},{"issue":"8","key":"3626_CR24","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/ddr.21726","volume":"81","author":"QQ Lu","year":"2020","unstructured":"Lu QQ, Chen YM, Liu HR, Yan JY, Cui PW, Zhang QF, et al. Nitrogen-containing flavonoid and their analogs with diverse B-ring in acetylcholinesterase and butyrylcholinesterase inhibition. Drug Dev Res. 2020;81(8):1037\u201347.","journal-title":"Drug Dev Res"},{"issue":"4","key":"3626_CR25","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/ddr.21515","volume":"80","author":"X-H Gao","year":"2019","unstructured":"Gao X-H, Tang J-J, Liu H-R, Liu L-B, Liu Y-Z. Structure\u2013activity study of fluorine or chlorine-substituted cinnamic acid derivatives with tertiary amine side chain in acetylcholinesterase and butyrylcholinesterase inhibition. Drug Dev Res. 2019;80(4):438\u201345.","journal-title":"Drug Dev Res"},{"issue":"39","key":"3626_CR26","doi-asserted-by":"publisher","first-page":"43759","DOI":"10.1039\/D6RA04515D","volume":"16","author":"SY Ewieda","year":"2026","unstructured":"Ewieda SY, Ziko L, Elshewy A, Salem M, Ibrahim ML, Lotfy Khaled M, et al. Design, synthesis, molecular docking and molecular dynamics simulations of pyrazolo[3,4-d]pyrimidine scaffolds as selective COX-2 and CDK2 kinase inhibitors with dual anti-inflammatory and anti-proliferative activities. RSC Adv. 2026;16(39):43759\u201377.","journal-title":"RSC Adv"},{"key":"3626_CR27","doi-asserted-by":"crossref","unstructured":"Al-Oudat BA, Audat SA, Al-Shar\u2019i NA, Al-Balas QA, Jaradat HM, Fakhouri L et al. Design, synthesis and biological evaluation of benzimidazole\/bis-imine derivatives as glyoxalase I inhibitors. Med Chem Res. 2025;34(5),1104-1121.","DOI":"10.1007\/s00044-025-03404-6"},{"issue":"Pt 6","key":"3626_CR28","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1042\/bst0311343","volume":"31","author":"PJ Thornalley","year":"2003","unstructured":"Thornalley PJ. Glyoxalase I\u2013structure, function and a critical role in the enzymatic defence against glycation. Biochem Soc Trans. 2003;31(Pt 6):1343\u20138.","journal-title":"Biochem Soc Trans"},{"key":"3626_CR29","doi-asserted-by":"publisher","first-page":"109486","DOI":"10.1016\/j.bioorg.2026.109486","volume":"170","author":"SY Ewieda","year":"2026","unstructured":"Ewieda SY, Ahmed EM, Halim PA, Ibrahim SG, Gouda KM, Abdalla M, et al. Discovery of novel pyridazinone derivatives as EGFRWT\/ EGFRT790M kinase inhibitors; design, synthesis, antitumor evaluation, and molecular dynamic simulations. Bioorg Chem. 2026;170:109486.","journal-title":"Bioorg Chem"},{"key":"3626_CR30","doi-asserted-by":"publisher","first-page":"109157","DOI":"10.1016\/j.bioorg.2025.109157","volume":"166","author":"SY Ewieda","year":"2025","unstructured":"Ewieda SY, Ahmed EM, Gohar NA, Ibrahim SG, Essa MA, Nemr MT. Design, synthesis, and antitumor evaluation of new pyridazinone scaffolds as dual EGFR\/VEGFR-2 kinase inhibitors and apoptotic cells inducers. Bioorg Chem. 2025;166:109157.","journal-title":"Bioorg Chem"},{"issue":"1","key":"3626_CR31","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41598-025-33678-0","volume":"16","author":"YH Zaki","year":"2026","unstructured":"Zaki YH, Zaki MEA, Farag B, Gomha SM. Synthesis, docking, SAR and ADMET evaluation of novel pyrrolo[3,4-c]pyrazole-4,6-dione derivatives. Sci Rep. 2026;16(1):628.","journal-title":"Sci Rep"},{"issue":"42","key":"3626_CR32","doi-asserted-by":"publisher","first-page":"e04601","DOI":"10.1002\/slct.202504601","volume":"10","author":"MT Nemr","year":"2025","unstructured":"Nemr MT, Fadaly WA, Abdelaziz MA. Pharmaceutical Applications of Di\/Tri-Aryl Pyrazole Derivatives: A Review on Recent Updates. ChemistrySelect. 2025;10(42):e04601.","journal-title":"ChemistrySelect"},{"key":"3626_CR33","doi-asserted-by":"crossref","unstructured":"Nemr M, Ziko L, Ghonaim L, Sonousi A. Design, Synthesis, and Antibacterial Evaluation of Novel Non-Oxazolidinone Analogues of Linezolid to Investigate the Role of the Oxazolidinone Ring. ChemistrySelect. 2026;11(32):e74242.","DOI":"10.1002\/slct.74242"},{"issue":"16","key":"3626_CR34","doi-asserted-by":"publisher","first-page":"115608","DOI":"10.1016\/j.bmc.2020.115608","volume":"28","author":"BA Al-Oudat","year":"2020","unstructured":"Al-Oudat BA, Hana\u2019a MJ, Al\u2013Balas QA, Al-Shar\u2019i NA, Bryant-Friedrich A, Bedi MF. Design, synthesis and biological evaluation of novel glyoxalase I inhibitors possessing diazenylbenzenesulfonamide moiety as potential anticancer agents. Bioorg Med Chem. 2020;28(16):115608.","journal-title":"Bioorg Med Chem"},{"key":"3626_CR35","doi-asserted-by":"publisher","first-page":"873","DOI":"10.2147\/DDDT.S356621","volume":"16","author":"SA Audat","year":"2022","unstructured":"Audat SA, Al-Balas QA, Al-Oudat BA, Athamneh MJ, Bryant-Friedrich A. Design, Synthesis and Biological Evaluation of 1,4-Benzenesulfonamide Derivatives as Glyoxalase I Inhibitors. Drug Des Devel Ther. 2022;16:873\u201385.","journal-title":"Drug Des Devel Ther"},{"key":"3626_CR36","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.2147\/DDDT.S110997","volume":"10","author":"QA Al-Balas","year":"2016","unstructured":"Al-Balas QA, Hassan MA, Al-Shar\u2019i NA, Mhaidat NM, Almaaytah AM, Al-Mahasneh FM, et al. Novel glyoxalase-I inhibitors possessing a zinc-binding feature as potential anticancer agents. Drug Des Devel Ther. 2016;10:2623.","journal-title":"Drug Des Devel Ther"},{"issue":"11","key":"3626_CR37","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.2174\/1570180814666170306120954","volume":"14","author":"A Al-Balasa","year":"2017","unstructured":"Al-Balasa A, A Hassana Q, Al Jabala MA, Al-Shar GA, Almaaytahb NM, El-Elimata A. Novel thiazole carboxylic acid derivatives possessing a zinc binding feature as potential human glyoxalase-I inhibitors. Lett Drug Des Discovery. 2017;14(11):1324\u201334.","journal-title":"Lett Drug Des Discovery"},{"issue":"1","key":"3626_CR38","doi-asserted-by":"publisher","first-page":"9945","DOI":"10.1038\/s41598-026-40497-4","volume":"16","author":"M Al-Qazzan","year":"2026","unstructured":"Al-Qazzan M, Al-Balas Q, Alnajjar B, Al-Akeedi M. Discovery of hydroxytriazole as a potential glyoxalase-I inhibitor utilizing computer-aided drug design techniques. Sci Rep. 2026;16(1):9945.","journal-title":"Sci Rep"},{"key":"3626_CR39","doi-asserted-by":"crossref","unstructured":"Al-Oudat BA, Audat SA, Al-Shar\u2019i NA, Al-Balas QA, Jaradat HM, Fakhouri L et al. Design, synthesis and biological evaluation of benzimidazole\/bis-imine derivatives as glyoxalase I inhibitors. Med Chem Res. 2025;34(5),1104-1121","DOI":"10.1007\/s00044-025-03404-6"},{"issue":"10","key":"3626_CR40","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1007\/s00044-024-03289-x","volume":"33","author":"BA Al-Oudat","year":"2024","unstructured":"Al-Oudat BA, Abu Al fool BS, Audat SA, Al-Shar\u2019i NA, Al-Balas QA, Zayed A, et al. Structural optimization and biological evaluation of quinoline\/naphthalene-based glyoxalase-I inhibitors as anti-cancer candidates. Med Chem Res. 2024;33(10):1897\u2013913.","journal-title":"Med Chem Res"}],"container-title":["Medicinal Chemistry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03626-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00044-026-03626-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03626-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:02:58Z","timestamp":1790636578000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00044-026-03626-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":40,"alternative-id":["3626"],"URL":"https:\/\/doi.org\/10.1007\/s00044-026-03626-2","relation":{},"ISSN":["1054-2523","1554-8120"],"issn-type":[{"value":"1054-2523","type":"print"},{"value":"1554-8120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"15 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics and consent to participate declarations","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no declarations of interest.","order":2,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}